Drugs and the Genome - NO L.O.s Flashcards

1
Q

Give some examples of types of variants/mutations. (3)

A

Single nucleotide variants
Insertions and deletions
Copy Number Variants

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What is GWAS?

A

Large-scale genotyping (genome-wide association study)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What is the pattern of inheritance of familial hypercholesterolaemia?

A

Autosomal dominant

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What does familial hypercholesterolaemia cause?

A

Premature CHD 30-40yrs
5% MI under 50 yrs
Arcus, Xanthalasma, Tendon Xanthomata

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What causes the effects of familial hypercholesterolaemia?

A

Mutations in LDL receptor - gain of function mutation in PCSK9. This causes LDL receptors bound to PCSK9 to be digested in the lysosome, instead of the receptor being recycled.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

How common is familial hypercholesterolaemia?

A

1 in 250

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What three monoclonal antibodies inhibit PCSK9 to treat hyperlipidaemia?
Are they effective?

A

Evolocumab, alirocumab and bococizumab

Injectable & safe with 41% to 58% reduction in cholesterol

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What is the average life expectancy in cystic fibrosis?

A

37.4 years old

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

How many people are carriers of CF?

Which population is it more common in?

A

1 in 25

White Europeans

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What is the combination therapy for CF?

Who is suitable?

A

Combination of ivacaftor and lumacaftor

Ages 12 and older with the ∆F508 mutation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

How do ivacaftor and lumacaftor work?

A

Improve lung function, prevent channel degradation, improve channel function

IVACAFTOR - augments CFTR channel opening
LUMACAFTOR - facilitates ∆F508 mutant protein folding, lowers sweat chloride concentration

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Which gene is affected in CF?

A

CFTR

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

What is TALEN?

A

DNA-cutting enzyme - deactivates immune genes to avoid rejection and protect the new cells from anti-cancer drugs that the patient is taking.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What is the Thiopurine Methyl Transferase (TPMT) test?

A

A phenotypic test - TPMT metabolises azathioprine and
6-mercaptopurine. Thioguanine accumulation inversely related to TPMT activity. Associated with severe haemopoietic toxicity.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

What do VKORC1 polymorphisms affect?

A

30% of the dose variation - less susceptible to suppression by warfarin, e.g. African Americans.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Group A VKORC1 polymorphisms - what does this cause?

A

more rapid achievement of a therapeutic INR

17
Q

CYP2C9 polymorphisms explain 10% of the dose variation of warfarin, mostly in Europeans. How does this differ from VKORC1?

A

CYP2C9 polymorphisms do not influence time to effective INR as opposed to VKORC1, but they do shorten the time INR >4.

18
Q

Abacavir can cause a skin hypersensitivity reaction. How can this be tested for?

A

HLA-B*5701

19
Q

Trastuzumab (Herceptin) - what is this?

A

Herceptin targets the HER2 protein, present on cell surfaces. Overproduction of HER2 causes the uncontrollable cell growth.

20
Q

What is the HercepTest?

What two cancers is it used for?

A

Identifies breast cancers with HER2 overproduction and predicts response to Herceptin.
Also used in gastric cancer.

21
Q

What targeted therapy can be used for melanoma?

A

BRAF inhibitors

22
Q

What mutation does Gefitinib target? Which cancer?

A

Lung cancer - epidermal growth factor mutation